LXRX Q3 2020 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

LXRXLexicon Pharmaceuticals, Inc.

$693M

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$7M-97.7% YoY

Gross Profit

$6M90.5% margin

Operating Income

$87M1306.5% margin

Net Income

$83M1245.1% margin

EPS (Diluted)

$0.71

QoQ Revenue Growth

-27.6%

Cash Flow

Operating Cash Flow

-$40M

Free Cash Flow

-$40M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$179M

Total Liabilities

$91M

Stockholders' Equity

$88M

Cash & Equivalents

$52M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$294M	-97.7%
Gross Profit	$6M	$294M	-98.0%
Operating Income	$87M	$225M	-61.4%
Net Income	$83M	$226M	-63.5%